Duke Cancer

A new type of immunotherapy is giving hope to people with advanced small cell lung cancer when chemotherapy and other immunotherapies are no longer effective. duke.is/z/nu37 #LungCancer |#Immunotherapy | @DukeHealth

Scientists have identified a biological trigger that helps explain why many people with cancer lose muscle during treatment, a discovery that could lead to drugs to preserve strength and mobility. duke.is/p/8d6p #CancerBiology | #CancerResearch | @DukeMedSchool

Researchers at DCI are exploring a faster, less invasive way to detect and analyze head and neck cancers using light and artificial intelligence. duke.is/5/t62b #ThyroidCancer | #CancerResearch | @DukeMedSchool | @DukeEngineering

DCI's Center for Prostate & Urologic Cancers leads with innovative trials to improve treatment options and long-term outcomes for patients with bladder cancer. duke.is/j/g9p4 #BladderCancer | #CancerResearch | Duke Health

Cachexia was thought of as an untreatable byproduct of cancer. But a new understanding of it has led to a surge of research. DCI's Jeffrey Crawford, MD, spoke to @letswinpc about clinical trials. duke.is/5/fmzq #PancreaticCancer | @DukeMedSchool | @DukeHealth

DCI's Zhao Zhang, PhD, refuses to play it safe as he changes what we know about the biology of cancer. Through his studies and clinical trials, Dr. Zhang seeks to create therapies for killer cancers. duke.is/y/yrnu #CancerBiology | #Cancer Research | @DukeMedSchool

New results from a clinical trial led by DCI's Nicholas DeVito, MD, are the first to show potential of immunotherapy as the initial treatment for patients with the most common type of colorectal cancer. duke.is/r/d9j6 #ColorectalCancer | #Immunotherapy | @DukeHealth

Several studies have supported what many clinicians are seeing: a steady increase in patients under age 50 being diagnosed with colorectal cancer. Duke researchers are examining environmental or lifestyle factors. duke.is/c/7nvs #ColorectalCancer | @DukeHealth

As part of an @OncLive Peer Exchange series, DCI's Richard Riedel, MD, discusses contemporary multidisciplinary management of desmoid tumor across the full care continuum. duke.is/8/k2jz @DukeHealth

DCI's Georgia Beasley, MD, spoke at Melanoma Research Alliance’s 2026 Patient Forum on how melanoma patient samples drive research and why this contribution matters. duke.is/b/m59d #Melanoma | @DukeHealth

Duke Health is among the first centers in the United States to perform complex lung autotransplantation procedures to treat lung cancer, which can be a preferred alternative to standard pneumonectomy. duke.is/c/r8x7 #LungCancer | @DukeHealth

DCI Interim Executive Director Erik Sulman, MD, PhD, spoke on a panel at the @AmericanCancer and @ACSCAN North Carolina Research Symposium on updates and optimism about the future of cancer research. duke.is/6/bjtf #CancerResearch | @DukeRadOnc | @DukeMedSchool

Because small cell lung cancer (SCLC) is rare, less is known about the disease compared with other lung cancers. At DCI, thoracic oncology experts treat a high volume of patients with SCLC. duke.is/4/tc69 #LungCancer | @DukeHealth

New research led by DCI's Gerry Blobe, MD, PhD, sheds light on a long‑standing mystery in cancer biology and reveals a potential path toward more targeted treatments for pancreatic and other solid tumors. duke.is/n/bb6n #PancreaticCancer | @DukeMedSchool | @DukeHealth

DCI's Nelson Chao, MD, will lead an interactive presentation from @OncLive on the treatment landscape of graft-versus-host disease (GVHD). 📆 Wednesday, April 8 | 6:30-7:30 p.m. duke.is/v/jye4 @DukeHealth

Researchers in the @prtbtcatduke have identified a new therapeutic vulnerability in IDH-mutant astrocytomas and other gliomas. duke.is/p/3svc @DukeMets | @Dukeneurosurg

🎉 Congratulations to the nine DCI members who received distinguished professorships from @DukeU this year! duke.is/2/94e3 @DukeMedSchool

The Duke Center for Brain and Spine Metastasis provides comprehensive, multidisciplinary evaluation and treatment for patients with metastatic disease involving the brain and spine. physicians.dukehealth.org/articles/duke-… @DukeMets | @DukeHealth

Up to 30% of people with pancreatic cancer may benefit from Whipple surgery, which combined with chemotherapy is considered the most effective treatment. Duke surgeons perform more than 100 Whipple procedures annually. duke.is/g/hgfa #PancreaticCancer | @DukeHealth

Research led by DCI's Zhao Zhang, PhD, has discovered the keys to survival for a circular form of DNA that drives many aggressive cancers. Researchers plan to develop new therapies to target them. duke.is/8/uu78 @DukeMedSchool | @Duke_PCB | @prtbtcatduke